Waveline-001: Updated Results from a Phase 1 Dose Escalation and Cohort Expansion Study of Zilovertamab Vedotin (MK-2140) in Non-Hodgkin Lymphoma
| العنوان: | Waveline-001: Updated Results from a Phase 1 Dose Escalation and Cohort Expansion Study of Zilovertamab Vedotin (MK-2140) in Non-Hodgkin Lymphoma |
|---|---|
| المؤلفون: | Stephen E. Spurgeon, Matthew Mei, Paul M. Barr, Jacqueline C. Barrientos, Sven de Vos, Richard R. Furman, Krish Patel, Philip A. Thompson, Michael Y. Choi, Avyakta Kallam, Sirou Wang, Uzor C. Ogbu, Akash Nahar, Michael L. Wang |
| المصدر: | Blood. 140:6640-6641 |
| بيانات النشر: | American Society of Hematology, 2022. |
| سنة النشر: | 2022 |
| مصطلحات موضوعية: | Immunology, Cell Biology, Hematology, Biochemistry |
| تدمد: | 1528-0020 0006-4971 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_________::6afca5e55929c6b8b2bfcfeedf0054afTest https://doi.org/10.1182/blood-2022-163509Test |
| رقم الانضمام: | edsair.doi...........6afca5e55929c6b8b2bfcfeedf0054af |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15280020 00064971 |
|---|